NCT05756582 Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students
| NCT ID | NCT05756582 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Eleonora Nucera |
| Condition | Tuberculosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,040 participants |
| Start Date | 2021-11-17 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,040 participants in total. It began in 2021-11-17 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a cross-sectional study that examines the prevalence of Latent Tuberculosis Infection \[LTBI\], defined as individuals infected with Mycobacterium tuberculosis with no clinical evidence of disease, and the possible risk factors of LTBI in a large cohort of health care workers (HCWs) and students.
Eligibility Criteria
Inclusion Criteria: * all health-care workers of Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, * all students of all three-year and single-cycle degree courses, master's degree courses, graduate schools of the faculty of Medicine and Surgery of the Catholic University of Sacred Heart in Rome, trained at the Fondazione Policlinico Universitario A. Gemelli IRCCS, * written informed consent. Exclusion Criteria: * denied informed consent.
Contact & Investigator
Angela Rizzi, MD, PhD
PRINCIPAL INVESTIGATOR
Catholic University of Sacred Heart
Frequently Asked Questions
Who can join the NCT05756582 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 72 Years, studying Tuberculosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05756582 currently recruiting?
Yes, NCT05756582 is actively recruiting participants. Contact the research team at angela.rizzi@policlinicogemelli.it for enrollment information.
Where is the NCT05756582 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT05756582 clinical trial?
NCT05756582 is sponsored by Eleonora Nucera. The principal investigator is Angela Rizzi, MD, PhD at Catholic University of Sacred Heart. The trial plans to enroll 2,040 participants.